Public research footprint of AO Ordine Mauriziano di Torino, compiled from the ClinicalTrials.gov public registry.
Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating… · Ulcerative Colitis and Crohn's Disease · Chronic Myeloid Leukemia (CML) · Primary Immune Thrombocytopenia (ITP)
Enter your work email to view the full list.
Verify and correct how your facility appears in public registry records — free.
Verify this profile →Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.